Actor portrayal. Not an actual patient.

Don’t let your patients drown in the risks of dangerously high triglycerides

Severe hypertriglyceridemia (sHTG) increases the risk of potentially life-threatening outcomes, including acute pancreatitis and atherosclerotic cardiovascular disease.1-3

Turn the tide on triglycerides now

Trigylceride icon
Triglyceride
sHTG is defined as fasting triglyceride levels ≥500 mg/dL.1
Bar chart icon illustrates sHTG risk assessment

The risks associated with sHTG vary depending on triglyceride level1

Understand the risks of sHTG
Clipboard icon illustrates calculating a patient's sHTG clinical score

Could your patient have familial chylomicronemia syndrome, a genetic form of sHTG?4

Calculate their clinical score

References

References

  1. Virani SS, Morris PB, Agarwala A, et al. 2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American College of Cardiology solution set oversight committee. J Am Coll Cardiol. 2021;78(9):960-993.

  2. Nawaz H, Koutroumpakis E, Easler J, et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. Am J Gastroenterol. 2015;110(10):1497-1503.

  3. Arca M, Veronesi C, D’Erasmo L, et al. Association of hypertriglyceridemia with all-cause mortality and atherosclerotic cardiovascular events in a low-risk Italian population: the TG-REAL retrospective cohort analysis. J Am Heart Assoc. 2020;9(19):e015801.

  4. D’Erasmo L, Di Costanzo A, Cassandra F, et al. Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes. Arterioscler Thromb Vasc Biol. 2019;39(12):2531-2541.